NRN1 and melanoma: Notably, soluble NRN1 promotes the migration of melanocyte cells and higher serum NRN1 levels were observed in melanoma patients compared with healthy donors, indicating that soluble NRN1 may also be a potential diagnostic biomarker in RCC patients (21).